Why is Bharat Immunolog falling/rising?
2025-10-31 22:41:08As of 31-Oct, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 20.28, which reflects a decrease of 0.31 or 1.51%. The stock has underperformed its sector by 1.06% today and has been on a downward trend for the last two days, resulting in a total drop of 3.57% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has decreased by 2.31%, and it has seen a significant decline of 14.75% year-to-date, compared to a positive return of 7.42% for the benchmark Sensex. Notably, there has been a rise in investor participation, with delivery volume increasing by 141.98% against the 5-day average, suggesting some interest despite the overall negative performance. In the broader market context, the stock's recent performance contras...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-24 22:23:05As of 24-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.54, down by 0.05 or 0.23%. The stock has been losing value for the last three days, with a total decline of 1.96% during this period. It is trading below all its moving averages, indicating a bearish trend. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. Additionally, the net sales have decreased significantly by 87.03% in the latest reporting period, and the operating cash flow is at its lowest. The high debt-to-equity ratio and consistent underperformance against benchmarks further contribute to the stock's weak outlook. In the broader market context, Bharat Immunological's performance over the past week shows a decline of 2.09%, while the Sensex has only fallen by 1.18%. This indicates that the stock is ...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-23 22:34:11As of 23-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.59, which reflects a decrease of 0.18 or 0.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -1.55% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 47.81% compared to the 5-day average, suggesting a decline in investor participation. There are no positive or negative factors available to provide further context on the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has shown a slight decline of 0.34% over the past week, Bharat Immunological has underperformed with a drop of 2.44%. Over the past month, while the Se...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-22 22:23:17As of 22-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.77, reflecting a change of -0.16, or -0.73%. The stock has underperformed in the short term, with a 1-week return of -0.91% and a 1-month return of -3.80%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 246.56% against the 5-day average, suggesting some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent movement. In the broader market context, the stock's performance contrasts sharply with the benchmark Sensex, which has gained 0.46% over the past week and 1.05% over the pa...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-19 22:17:26As of 19-Sep, Bharat Immunological & Biological Corporation Ltd is currently priced at 22.01, reflecting a slight increase of 0.09 or 0.41%. The stock has shown a trend reversal by gaining after two consecutive days of decline. However, it is trading below all its moving averages, indicating a bearish trend. The stock's performance over the past week is relatively in line with the sector, but it has underperformed significantly over longer periods, with a year-to-date decline of 7.48% and a one-year drop of 21.78%. Key negative factors contributing to the stock's recent movement include weak long-term fundamentals, as the company has not declared results in the last six months, and a concerning debt-to-EBITDA ratio. Additionally, net sales have plummeted by 87.03% in the latest reporting period, further exacerbating investor concerns. In the broader market context, the stock's short-term performance has la...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-18 22:19:42As of 18-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.92, which reflects a decrease of 0.08 or 0.36%. The stock has underperformed its sector by 1.41% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 0.95% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past year, the stock has seen a significant decline of 24.98%, while the year-to-date performance shows a drop of 7.86%. There is no information available regarding positive or negative factors that could influence the stock's movement. Broader Market Context: In contrast to Bharat Immunological's performance, the benchmark Sensex has shown a positive return of 1.80% over the past week and 2.14% over the past month. This...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-17 22:09:59As of 17-Sep, Bharat Immunological & Biological Corporation Ltd's stock price is currently at 22.00, reflecting a decrease of 0.13, or 0.59%. The stock has underperformed its sector today by 0.63%, and while it is higher than its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a modest gain of 1.38%, but it has significantly underperformed the benchmark Sensex over the last month and year, with returns of -0.41% and -25.68%, respectively. The company has not declared results in the last six months, which raises concerns about its long-term fundamental strength, as evidenced by a drastic decline in net sales and operating profit over the past five years. Broader market context indicates that the stock's recent performance is not in line with the overall market trends, as the Sensex has gained 1.56% in the past week and ...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-16 22:15:46As of 16-Sep, Bharat Immunological & Biological Corporation Ltd is currently priced at 22.13, reflecting an increase of 0.16 or 0.73%. The stock has shown a trend reversal, gaining after two consecutive days of decline, and has outperformed its sector by 0.45%. However, despite this short-term uptick, the stock has underperformed against the benchmark Sensex over various periods, including a 1-year return of -24.70% compared to the Sensex's -0.73%. Additionally, the stock's delivery volume has decreased by 13.26% against the 5-day average, indicating falling investor participation. The company's long-term fundamentals are weak, with net sales declining at an annual rate of -24.67% and a high debt-to-EBITDA ratio, which raises concerns about its ability to service debt. In the broader market context, the stock's short-term performance of +0.91% over the past week is less than the Sensex's +1.58%, highlighti...
Read MoreWhy is Bharat Immunolog falling/rising?
2025-09-15 22:08:09As of 15-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a slight decline in its stock price, currently at 21.97, reflecting a decrease of 0.03 or 0.14%. The stock has been underperforming recently, having fallen consecutively for the last two days with a total return of -0.95%. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 75.83% compared to the 5-day average, which suggests a lack of confidence among investors. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's performance. In the broader market context, Bharat Immunological's performance over the past week shows a decline of 0.45%, while the benchmark Sensex has increased by 1.24%. This tren...
Read MoreBoard Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.
07-Aug-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.
29-Feb-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.
Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.
13-Dec-2023 | Source : BSESubmission of Draft Annual Report 2022-23 for AGM on 29.12.2023
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






